|
ERCC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.986400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.098600E-03 |
| Normal-vs-Stage2 |
6.446900E-04 |
| Normal-vs-Stage3 |
4.22560000000738E-05 |
| Normal-vs-Stage4 |
4.483000E-03 |
| Stage1-vs-Stage2 |
1.670240E-01 |
| Stage1-vs-Stage3 |
5.032500E-02 |
| Stage1-vs-Stage4 |
4.974400E-01 |
| Stage2-vs-Stage3 |
9.631800E-01 |
| Stage2-vs-Stage4 |
5.796400E-01 |
| Stage3-vs-Stage4 |
4.718400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.019400E-04 |
| Normal-vs-AfricanAmerican |
2.060400E-01 |
| Normal-vs-Asian |
3.746400E-01 |
| Caucasian-vs-AfricanAmerican |
2.167800E-01 |
| Caucasian-vs-Asian |
1.732270E-02 |
| AfricanAmerican-vs-Asian |
6.215600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.603600E-04 |
| Normal-vs-Female |
8.426300E-04 |
| Male-vs-Female |
5.160400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.399000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.357650E-04 |
| Normal-vs-Age(61-80Yrs) |
9.9941999999964E-05 |
| Normal-vs-Age(81-100Yrs) |
3.685700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.500240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.860100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.826200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.433400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.437800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.771200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.377300E-03 |
| Classical-VS-Follicular |
7.392100E-04 |
| Classical-VS-Other |
4.238800E-01 |
| Classical-VS-Normal |
1.440060E-02 |
| Tall-VS-Follicular |
9.553600E-01 |
| Tall-VS-Other |
6.176400E-01 |
| Tall-VS-Normal |
1.830050E-04 |
| Follicular-VS-Other |
6.619400E-01 |
| Follicular-VS-Normal |
4.8069000000428E-06 |
| Other-VS-Normal |
8.921500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.27029999999773E-05 |
| Normal-vs-N1 |
1.216080E-02 |
| N0-vs-N1 |
6.204400E-01 |
|
|
